Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine
- 23 October 2002
- Vol. 21 (9-10) , 946-949
- https://doi.org/10.1016/s0264-410x(02)00545-5
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responsesVaccine, 2001
- Phase 1 Evaluation of Intranasal Virosomal Influenza Vaccine with and withoutEscherichia coliHeat-Labile Toxin in Adult VolunteersJournal of Virology, 1999
- The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in miceVaccine, 1999
- The Serum Antibody Response Distributed in Subclasses and Isotypes after Intranasal and Subcutaneous Immunization with Influenza Virus Immunostimulating ComplexesScandinavian Journal of Immunology, 1988
- Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature, 1984
- Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccinePublished by American Medical Association (AMA) ,1969